Attending this event?
Back To Schedule
Monday, September 19 • 2:45pm - 3:30pm
Panel: Evaluate Innovative Deal Structures and How to Find the Right Partner

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

This session will cover deal making within the biotech industry and what to look for when evaluating potential partners from both the big pharma and biotech sides. What are the red flags to be aware of? What are the green flags to look for? There are many factors that impact who you should partner with and what to be looking for in a partner depending on the strategy. This panel will hear from several experienced deal makers who can speak to the motivations, decision-making process, and outcomes while finding the right partner.

avatar for Sarah Hogan

Sarah Hogan

Partner, WilmerHale
Sarah Hogan, a Partner at WilmerHale, advises companies in the life sciences and digital health industries in connection with structuring and negotiating intellectual property licenses, strategic collaborations and other complex commercial transactions. Drawing on her scientific background... Read More →

avatar for Abbas Kazimi

Abbas Kazimi

Chief Business Officer, Nimbus Therapeutics
Abbas Kazimi is Chief Business Officer at Nimbus Therapeutics. Over the course of his tenure at Nimbus he has helped drive multiple transformative transactions and has evolved the company’s business development and partnering strategy. In his role, he is also responsible for expanding... Read More →
avatar for Imran Nasrullah, MS, JD

Imran Nasrullah, MS, JD

Vice President & Head, Collaborate2Cure Hub US, Business Development & Licensing, Bayer Pharmaceuticals
Imran Nasrullah is an intrapreneur driving external innovation with entrepreneurs.  He possesses 25 years of business development & licensing, strategy, economic development, and technology transfer experience. Currently, Imran is Vice President and Head of the Collaborate to Cure... Read More →
avatar for Rachel Zolot Schwartz, MBA

Rachel Zolot Schwartz, MBA

VP, Head of Business Development and Commercial, Volastra Therapeutics
Rachel Zolot Schwartz is Head of Business Development & Commercial at Volastra Therapeutics, where she led the diligence, negotiation and contracting for the company’s first major pharma partnership, an up to $1.1B discovery deal with Bristol Myers Squibb. She has developed the... Read More →

Monday September 19, 2022 2:45pm - 3:30pm EDT